DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kato KS, Sun JM, Shah MA. et al.
Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: the phase 3 KEYNOTE-590 study.
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
Access:
We do not assume any responsibility for the contents of the web pages of other providers.